| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 3 | |||
| NCT06522737 | A Study of Duvelisib Versus Gemcitabine or Bendamustine in Participants With… | Lymphoma | Recruiting |
| Phase 2 | |||
| NCT07293403 | Duvelisib Maintenance for the Treatment of Peripheral T-Cell Lymphomas | Follicular Helper T-Cell Lymphoma | Recruiting |
| NCT03961672 | Intermittent Duvelisib Dosing in Treating Patients With Chronic Lymphocytic Leukemia or… | Recurrent Chronic Lymphocytic Leukemia | Active, Not Recruiting |
| Phase 1/2 | |||
| NCT02158091 | A Phase 1b/2 Study of IPI-145 Plus FCR in Previously Untreated, Younger Patients With CLL | Chronic Lymphocytic Leukemia | Active, Not Recruiting |
| NCT03534323 | Duvelisib and Venetoclax in Relapsed or Refractory CLL or SLL or RS | Chronic Lymphocytic Leukemia | Active, Not Recruiting |
| Phase 1 | |||
| NCT05010005 | A Study of Ruxolitinib and Duvelisib in People With Lymphoma | T-cell Lymphomas | Recruiting |
| NCT07001384 | A Study of Alectinib and Duvelisib in People With Anaplastic Lymphoma Kinase-Positive… | Anaplastic Lymphoma Kinase | Recruiting |
| NCT05044039 | Duvelisib Following Chimeric Antigen Receptor T-Cell Therapy | Non-hodgkin Lymphoma | Active, Not Recruiting |
| NCT04652960 | Duvelisib and Nivolumab for the Treatment of Stage IIB-IVB Mycosis Fungoides and Sezary… | Stage IIB Mycosis Fungoides and Sezary Syndrome AJCC v8 | Active, Not Recruiting |